Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Mussel adhesive protein product and applications thereof in suppression of skin inflammations

a technology of mussels and adhesive proteins, applied in the direction of peptide/protein ingredients, drug compositions, aerosol delivery, etc., can solve the problems of cytotoxicity, skin irritation, favorable treatment of skin inflammation, etc., to prolong the action time, prolong the defoaming time, and facilitate the attachment

Active Publication Date: 2018-08-16
BENGT I SAMUELSSON INST OF LIFE SCI CO LTD
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes a foam formulation of MAP (a mixture of an organic acid and a surfactant) that can be used to treat skin inflammation and other skin diseases. The foam formulation contains a foaming agent, which releases pressure during the defoaming process, allowing MAP to better attach to the skin and provide longer-lasting relief. Additionally, the foam formulation can also contain other components such as glycerin, polyethylene glycol, vitamins, and glutathione to further strengthen its moisturizing and anti-oxidation capabilities. The inventors have found that MAP has effective properties in reducing skin inflammation, including erythema, redness, swelling, edema, blisters, and bullous pemphigoid. The foam formulation is a non-steroidal and safe treatment option for skin inflammation and other skin diseases.

Problems solved by technology

When the concentration is overly low, MAP does not have a good effect, and when the concentration is overly high, it may cause cytotoxicity, skin irritation, etc., which is not favorable for treatment of skin inflammations.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mussel adhesive protein product and applications thereof in suppression of skin inflammations
  • Mussel adhesive protein product and applications thereof in suppression of skin inflammations

Examples

Experimental program
Comparison scheme
Effect test

example 1

Use of MAP Liquid Medical Device in Treatment of Eczema

[0093]Take 1 ml of an MAP solution with concentration at 20.0 mg / ml, add 9 ml of 0.1% citric acid solution, and prepare an MAP aqueous solution medical device with concentration at 2.0 mg / ml.

[0094]Gather 20 patients with acute eczema as diagnosed by dermatologists for test. Eczema locations are not limited for the selected patients, the affected areas are 1-2% TBSA (total body surface area), and the affected areas have patches of erythema, dense or dispersed small papules and blisters, or large patches of weeping liquid and ulceration.

[0095]For the selected patients, spray the above MAP aqueous solution medical device on the affected part, 3 times per day, and spray 3-5 times each time until the affected part is completely covered by the MAP aqueous solution medical device. After sprayed with the MAP aqueous solution medical device, itching at the affected part is significantly reduced within 2 to 10 min, the visual analogue sco...

example 2

Use of MAP Gel Medical Device in Treatment of Eczema

[0097]Add 10 g sodium carboxymethyl cellulose into 20 ml deionized water, place in a bath at 90° C. for 30 min until complete dissolution to obtain a gel matrix. Add 2.5 ml of an MAP solution with concentration at 10.0 mg / ml into the gel matrix, add slowly under constant stirring, and mix homogeneously to form an MAP gel medical device, wherein the MAP concentration is 1.1 mg / ml.

[0098]Gather 20 patients with acute eczema. Eczema locations are not specified for the selected patients, the affected areas are 1-2% TBSA (total body surface area). The patients are diagnosed by dermatologists, sign the informed consent form, and then join the clinical test. The affected areas of the patients have patches of erythema, dense or dispersed small papules and blisters, or large patches of weeping liquid and ulceration.

[0099]For the selected patients, apply the above MAP gel medical device on the affected part, 3 times per day, and spray 3-5 tim...

example 3

Use of MAP Gel Cosmetic in Treatment of Polymorphous Sunlight Eruption

[0101]Take an MAP solution with concentration at 0.5 mg / ml, mix with polyethylene glycol and glycerin at a volumetric ratio of 2:1:2, then add water for injection in an equal volume to prepare an MAP gel cosmetic, wherein the MAP content is 0.1 mg / g.

[0102]Gather 10 patients with acute inflammatory reaction after sunbath, it is required that the affected parts of the selected patients include the face or limbs, and the affected areas are no smaller than 1% TBSA (total body surface area). The patients are diagnosed by dermatologists for test. The affected parts of the selected patients have erythema, edema or blisters. Apply the above MAP gel cosmetic at the affected part for 3 times per day, and evenly apply the gel on the surface of the affected part each time. After applied with the MAP gel cosmetic, mitigation of itching and pain occurs to all the 10 patients, the onset time varies from 3 to 20 min, and the itch...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

Disclosed are applications of a mussel adhesive protein or preparations thereof in suppression of skin inflammations. Specifically disclosed are applications of a mussel adhesive protein, preparations thereof and applications thereof in dermatitis, eczema, skin ulcer, technologies related to burns (comprising skin grafting), perniones, surgical incisions, herpes, abrasions, scars, psoriasis, erythema multiforme, skin damage after radiotherapy, skin cancers, folliculitis, urticaria and drug eruption, and applications in sunburn, polymorphous light eruption, pathological alopecia (comprising hair transplant), acne vulgaris, rosacea (that is, acne rosacea), and the like, and applications in the treatment of otitis externa.

Description

FIELD OF THE INVENTION[0001]The present invention substantially relates to the technical field of drugs, cosmetics, medical products, disinfecting products, healthcare products, food, and household chemicals, and more specifically, relates to a mussel adhesive protein product and a use thereof for inhibiting skin inflammation.DESCRIPTION OF THE RELATED ART[0002]As the first physiological barrier and the largest organ of human body, skin always participates in functional activities of the body, maintains the unity of opposites between the body and natural environment. Moreover, any abnormal conditions of the body could be reflected from the skin surface as well. Skin consists of epidermis, dermis and subcutaneous tissues, and comprises numerous auxiliary organs, such as follicle glands, sebaceous glands, finger nails, toe nails, blood vessels, lymphatic ducts, nerves and muscles. Skin has almost perfect capabilities of physiological protection, such as barrier function, perception fu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/39A61K38/17A61K9/00A61K9/06A61K9/70A61P17/04A61P29/00A61P17/02A61P31/22A61P17/06A61P17/00
CPCA61K38/39A61K38/1767A61K9/0014A61K9/06A61K9/7023A61P17/00A61P29/00A61P17/02A61P31/22A61P17/06A61P17/04A61K47/10A61K47/38A61K9/122A61K35/618A23L33/18A61K8/64A61K9/12A61K38/17A61Q19/00A23V2002/00A23V2200/318A61P17/10
Inventor SAMUELSSON, INGEMAR BENGTGAO, MIN
Owner BENGT I SAMUELSSON INST OF LIFE SCI CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com